Yes. She can't be worse than the pathetic Board the company now has who's only interest is how much cheap stock options they can give themselves and cash in at shareholders expense. The current BOD is one of the worst I have ever seen
We have had pathetic board members and it is about time someone good is added to the Board. She will be an asset to the company and shareholders.
Dr. Smith has extensive strategic, operational and management experience in the biopharmaceutical industry. She is the former CEO of the NeoStem family of companies1, which she led as CEO from 2006 to 2015 and established as one of the preeminent healthcare brands focused on the development of cellular therapies. During her tenure, Dr. Smith pioneered the company's innovative business model building proprietary cell therapy development and a successful commercial contract and manufacturing organization. At NeoStem, Dr. Smith raised over $200 million while completing six acquisitions and one divestiture of a company in the pharmaceutical space that achieved a doubling of revenues during her tenure. Dr. Smith has also held various board positions and served in senior management roles for numerous medical and healthcare based entities.
No way to know about Calcitriol but its doubtful if it was launched. I wouldn't expect anything until the end of the year. Management consistently misses every milestone they set (forward looking statements). No one knows about CMS decision either. Chioini sounded like a decision was imminent in the last CC so the lack of any news is not good. Could mean CMS said no and company is appealing their decision. If CMS rejected and Chioini is withholding it from investors the company has major issues and more lawsuits ahead of it..
Metropolitan Life Insurance Co. NY increased its position in shares of Rockwell Medical Inc (NASDAQ:RMTI) by 26.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,247 shares of the company’s stock after buying an additional 9,178 shares during the period. Metropolitan Life Insurance Co. NY owned approximately 0.08% of Rockwell Medical worth $325,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Rehmann Capital Advisory Group boosted its stake in shares of Rockwell Medical by 3.6% in the first quarter. Rehmann Capital Advisory Group now owns 17,286 shares of the company’s stock valued at $130,000 after buying an additional 600 shares during the period. Provident Investment Management Inc. boosted its position in shares of Rockwell Medical by 4.0% in the first quarter. Provident Investment Management Inc. now owns 26,108 shares of the company’s stock valued at $196,000 after buying an additional 1,000 shares in the last quarter. BlackRock Group LTD boosted its position in shares of Rockwell Medical by 265.1% in the first quarter. BlackRock Group LTD now owns 28,328 shares of the company’s stock valued at $213,000 after buying an additional 20,570 shares in the last quarter. UBS Group AG boosted its position in shares of Rockwell Medical by 45.8% in the first quarter. UBS Group AG now owns 68,900 shares of the company’s stock valued at $517,000 after buying an additional 21,629 shares in the last quarter. Finally, A.R.T. Advisors LLC acquired a new position in shares of Rockwell Medical during the first quarter valued at approximately $593,000.
Interesting it was rejected by shareholders. Management getting way too much stock at this point. I realize most didn't vote on it but am glad it was defeated. They need to focus more on shareholder value at this point.